Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 18 Oct 2023

Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Chuchu Xu
Yian Chen
Qinghong Yu
Jiaqing Song
Ying Jin
Xiufei Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243286

5,329 views
10 citations

Original Research

Published on 17 Oct 2023

Methotrexate-conjugated zinc oxide nanoparticles exert a substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis

in Pharmacology of Anti-Cancer Drugs

Prakriti Mishra
Mohd Faizan Ali Ahmad
Lamya Ahmed Al-Keridis
Mohd Saeed
Nawaf Alshammari
Nadiyah M. Alabdallah
Rohit Kumar Tiwari
Afza Ahmad
Mahima Verma
Shireen Fatima

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194578

3,816 views
7 citations

Review

Published on 16 Oct 2023

Research progress on the chemical components and biological activities of sea cucumber polypeptides

in Pharmacology of Anti-Cancer Drugs

Yiwen Shou
Chao Feng
Qinpei Lu
Xin Mao
Huisha Huang
Zhiheng Su
Hongwei Guo
Zhaoquan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290175

5,051 views
8 citations

Methods

Published on 13 Oct 2023

Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies

in Pharmacology of Anti-Cancer Drugs

Nicola Melillo
Jake Dickinson
Lu Tan
Hitesh B. Mistry
Heinrich J. Huber

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1272058

2,982 views

Case Report

Published on 13 Oct 2023

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Nan Zhou
Chuan-Fen Lei
Si-Rui Tan
Qi-Yue Huang
Shun-Yu Zhang
Zheng-Xin Liang
Hong-Feng Gou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190967

3,234 views
5 citations

Original Research

Published on 13 Oct 2023

Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Xiaoqian Yu
Xuejie Yang
Hui Nie
Wenying Jiang
Xiaoyun He
Chunlin Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1255809

2,416 views
1 citation

Review

Published on 11 Oct 2023

The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Huijie Zhao
Yanting Zhang
Xiaodi Fu
Chaoren Chen
Saadullah Khattak
Honggang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1280308

3,374 views
10 citations

Original Research

Published on 06 Oct 2023

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity

in Pharmacology of Anti-Cancer Drugs

Huaxia Xie
Longfei Mao
Gaolu Fan
Ziyuan Wu
Yimian Wang
Xixi Hou
Jiangang Wang
Huili Wang
Ling Liu
Sanqiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265289

2,984 views
10 citations

Original Research

Published on 04 Oct 2023

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

in Pharmacology of Anti-Cancer Drugs

Wing Lam
Mohammad Arammash
Wei Cai
Fulan Guan
Zaoli Jiang
Shwu-Huey Liu
Peikwen Cheng
Yung-Chi Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244655

4,356 views
1 citation

Review

Published on 04 Oct 2023

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives

in Pharmacology of Anti-Cancer Drugs

Qingmei Ye
Xin Zhou
Han Ren
Fangxuan Han
Rong Lin
Juan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274336

3,922 views
8 citations

Original Research

Published on 04 Oct 2023

Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis

in Pharmacology of Anti-Cancer Drugs

Gabriele Strusi
Caterina M. Suelzu
Nicole Horwood
Andrea E. Münsterberg
Yongping Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264032

3,228 views
8 citations

Review

Published on 03 Oct 2023

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Yulin Hou
Jie Wang
Jianping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284406

2,356 views
3 citations

Correction

Published on 29 Sep 2023

Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells

in Pharmacology of Anti-Cancer Drugs

Ahmed Alafnan
Nasrin E. Khalifa
Talib Hussain
Mhdia Elhadi Osman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286507

1,542 views

Review

Published on 28 Sep 2023

Lipid metabolism as a target for cancer drug resistance: progress and prospects

in Pharmacology of Anti-Cancer Drugs

Zi’an Wang
Yueqin Wang
Zeyun Li
Wenhua Xue
Shousen Hu
Xiangzhen Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274335

7,097 views
26 citations

Original Research

Published on 28 Sep 2023

A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients

in Pharmacology of Anti-Cancer Drugs

Bertalan Fekete
Lili Bársony
Krisztina Biró
Fruzsina Gyergyay
Lajos Géczi
Attila Patócs
Barna Budai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220457

2,662 views

Systematic Review

Published on 28 Sep 2023

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies

in Pharmacology of Anti-Cancer Drugs

Amir Taldaev
Roman Terekhov
Ilya Nikitin
Elizaveta Melnik
Vera Kuzina
Mikhail Klochko
Igor Reshetov
Artem Shiryaev
Victor Loschenov
Galina Ramenskaya

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264961

137,432 views
18 citations